dc.date.accessioned | 2015-07-23T15:35:26Z | |
dc.date.available | 2015-07-23T15:35:26Z | |
dc.date.issued | 1989-05-02 | |
dc.identifier | pat4826984 | |
dc.identifier.uri | https://hdl.handle.net/11244/15336 | |
dc.description.abstract | Novel heteroarotinoid compositions characterized by the formulae: ##STR1## where R is H, CH.sub.3 or C.sub.2 H.sub.5 and X is S, S O, O, NCH.sub.3, Si(CH.sub.3).sub.2, N.sup.+ (H)CH.sub.3 [Cl.sup.- ], N.sup.+ (H)CH.sub.3 [Br.sup.- ] or N.sup.+ (alkyl) CH.sub.3 [Cl.sup.- or Br.sup.-) where alkyl is CH.sub.3, C.sub.2 H.sub.5, CH.sub.2 .dbd.CHCH.sub.2 or C.sub.6 H.sub.5 CH.sub.2. Such compositions exhibit activity as anticancer agents. | |
dc.format | application/pdf | |
dc.format.extent | 19 pages | |
dc.language | en_US | |
dc.publisher | U.S. Patent and Trademark Office | |
dc.title | Heteroarotinoid Compounds as Anticancer Agents | |
dc.type | text | |
osu.filename | pat4826984.pdf | |
osu.accesstype | Open Access | |
dc.type.genre | Patent | |
dc.contributor.inventor | Berlin, Kenneth Darrell | |
dc.contributor.inventor | Holt, Elizabeth M. | |
dc.contributor.inventor | Ford, Warren T. | |
dc.contributor.inventor | Thompson, Mark D. | |
dc.identifier.patentID | 4,826,984 | |
dc.date.filed | 1987-01-27 | |
dc.contributor.assignee | Board of Regents/Oklahoma State University and the A & M Colleges | |
dc.subject.primaryusclass | 546/134 | |
dc.subject.otherusclasses | 548/469 | |
dc.subject.otherusclasses | 549/23 | |
dc.subject.otherusclasses | 549/407 | |
dc.subject.otherusclasses | 549/462 | |
dc.subject.otherusclasses | 549/58 | |
dc.subject.otherusclasses | 556/406 | |
dc.subject.cpcclasses | C07D 307/79 (20130101) | |
dc.subject.cpcclasses | C07D 311/58 (20130101) | |
dc.subject.cpcclasses | C07D 409/12 (20130101) | |
dc.subject.cpcclasses | C07D 335/06 (20130101) | |
dc.subject.cpcclasses | C07D 333/54 (20130101) | |